Anti-HLA alloantibodies in pediatric solid organ transplantation

Pediatric Transplantation

Volumn 10, Issue 2, 2006, Pages 146-153

  Girnita, Alin L ^a   Webber, Steven A ^b   Zeevi, Adriana ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c E1354 BST   (United States)

Author keywords

Antibody mediated rejection; Human leucocyte antigen; Pediatric transplantation

Indexed keywords

ALEMTUZUMAB; ALLOANTIBODY; ANTIBODY; B LYMPHOCYTE ANTIBODY; BIOLOGICAL MARKER; CD20 ANTIBODY; CD3 ANTIBODY; COMPLEMENT; HLA ANTIBODY; HLA ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; RITUXIMAB; THYMOCYTE ANTIBODY;

ALLOGRAFT; ALLOIMMUNITY; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; BLOOD VESSEL GRAFT; CELL ASSAY; COMPLEMENT ACTIVATION; DEPLETION; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOLOGY; HUMAN; KIDNEY ALLOGRAFT; LIVER GRAFT; LUNG TRANSPLANTATION; ORGAN TRANSPLANTATION; PEDIATRIC SURGERY; PLASMAPHERESIS; REVIEW; SCREENING; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPLENECTOMY;

CHILD; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEART TRANSPLANTATION; HLA ANTIGENS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 33645107871     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2005.00425.x     Document Type: Review

References (74)

1. P atel R T erasaki PI Significance of the positive crossmatch test in kidney transplantation N Engl J Med 1969 280 735 739
2. D i F ilippo S G irnita A W ebber SA et al. Impact of ELISA-detected anti-HLA antibodies on pediatric cardiac allograft outcome Hum Immunol 2005 66 513 518
3. G irnita AL M c C urry KR I acono AT et al. HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection J Heart Lung Transplant 2004 23 1135 1141
4. G irnita AL D uquesnoy R Y ousem SA et al. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction Am J Transplant 2005 5 131 138
5. M c K enna RM T akemoto SK T erasaki PI Anti-HLA antibodies after solid organ transplantation Transplantation 2000 69 319 326
6. T erasaki PI Humoral theory of transplantation Am J Transplant 2003 3 665 673
7. D avenport A Y ounie ME P arsons JE K louda PT Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection Nephrol Dial Transplant 1994 9 1315 1319
8. B ray RA N ickerson PW K erman RH G ebel HM Evolution of HLA antibody detection: technology emulating biology Immunol Res 2004 29 41 54
9. D alla V ecchia LK B ook BK M ilgrom ML et al. Predictive value of enzyme-linked immunosorbent assay-detected IgG anti-HLA antibodies for pediatric renal allograft rejection Transplantation 1997 64 1744 1747
10. R acusen LC H alloran PF S olez K Banff 2003 meeting report: new diagnostic insights and standards Am J Transplant 2004 4 1562 1566
11. H osenpud JD B ennett LE Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the joint UNOS/ISHLT thoracic registry Transplantation 2001 72 1662 1665
12. G jertson DW D abrowska DM C ui X C ecka JM Four causes of cadaveric kidney transplant failure: A competing risk analysis Am J Transplant 2002 2 84 93
13. I tescu S T ung TC B urke EM et al. Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation Circulation 1998 98 786 793
14. O pelz G W ujciak T D ohler B S cherer S M ytilineos J HLA compatibility and organ transplant survival. Collaborative Transplant Study Rev Immunogenet 1999 1 334 342
15. M c K enna RM T akemoto SK Improving HLA matching for kidney transplantation by use of CREGs Lancet 2000 355 1842 1843
16. E l -A war N T erasaki P L azda V N ikaein A A rnold A Most patients who reject a kidney transplant have anti-HLA-antibodies Tissue Antigens 2002 60 553
17. G irnita A D uquesnoy R D emetris A et al. De novo anti-HLA antibodies have the highest incidence in the first year after transplantation Hum Immunol 2003 64 S77
18. G lotz D A ntoine C J ulia P et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg) Am J Transplant 2002 2 758 760
19. J ordan SC V o A B unnapradist S et al. Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients Transplantation 2003 76 631 636
20. A l -U zri AY S eltz B Y orgin PD S pier CM A ndreoni K Successful renal transplant outcome after intravenous gamma-globulin treatment of a highly sensitized pediatric recipient Pediatr Transplant 2002 6 161 165
21. W orthington JE T homas AA D yer PA M artin S Detection of HLA-specific antibodies by PRA-STAT and their association with transplant outcome Transplantation 1998 65 121 125
22. D uquesnoy RJ M arrari M HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes Hum Immunol 2002 63 353 363
23. N elson K M arks W W arner P T hompson C D avis C Acute humoral rejection is associated with antibodies to HLA-DP Am J Transplant 2005 5 72 73
24. H oekstra F W itvliet M K noop C et al. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts J Heart Lung Transplant 1997 16 570 572
25. J aramillo A S mith MA P helan D et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation Transplantation 1999 67 1155 1161
26. P almer SM D avis RD H adjiliadis D et al. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome Transplantation 2002 74 799 804
27. S usal C P elzl S S imon T O pelz G Advances in pre- and posttransplant immunologic testing in kidney transplantation Transplant Proc 2004 36 29 34
28. G ammie JS P ham SM C olson YL et al. Influence of panel-reactive antibody on survival and rejection after lung transplantation J Heart Lung Transplant 1997 16 408 415
29. A deyi OA G irnita AL H owe J et al. Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches Transpl Immunol 2005 14 53 62
30. H osenpud JD M auck KA H ogan KB Cardiac allograft vasculopathy: IgM antibody responses to donor-specific vascular endothelium Transplantation 1997 63 1602 1606
31. M c C almon RT Jr. T ardif GN S heehan MA F itting K K ortz W K am I IgM antibodies in renal transplantation Clin Transplant 1997 11 558 564
32. D oran TJ S usal C O pelz G G eczy AF IgA class antibodies and flow cytometric cross-matching in renal transplantation Transplantation 1999 67 309 314
33. F ine RN M alekzadeh MH P ennisi AJ E ttenger RB U ittenbogaart CH K orsch BM Renal retransplantation in children J Pediatr 1979 95 244 248
34. D 'Apice AJ S heil AG T ait BD B ashir HV A prospective randomized trial of matching for HLA-A and B versus HLA-DR in renal transplantation Transplantation 1984 38 37 41
35. B royer M G agnadoux MF G uest G B usson M B eurton D Results of 310 cadaver kidney transplants in children and adolescents Arch Fr Pediatr 1985 42 237 243
36. D yer PA M artin S M allick NP G okal R J ohnson RW Kidney transplantation in the northwest region of England - experience of 1,132 transplants in 21 years Clin Transpl 1989 201 213
37. D elmonico FL T olkoff -R ubin N A uchincloss H Jr. et al. Second renal transplantations. Ethical issues clarified by outcome; outcome enhanced by a reliable crossmatch Arch Surg 1994 129 354 360
38. E monds MP H erman J D endievel J W aer M V an D amme -L ombaerts R Evaluation of anti-human leukocyte antigen allo-immunization in pediatric cadaveric kidney transplantation Pediatr Transplant 2000 4 6 11
39. P iatosa B G renda R R ubik J P rokurat S The significance of anti-HLA antibody presence in children who lost the transplanted kidney due to vascular thrombosis Transplant Proc 2002 34 589 590
40. B reinholt JP III. H awkins JA L ambert LM F uller TC P rofaizer T S haddy RE A prospective analysis of the immunogenicity of cryopreserved nonvalved allografts used in pediatric heart surgery Circulation 2000 102 III179 III182
41. H awkins JA B reinholt JP L ambert LM et al. Class I and class II anti-HLA antibodies after implantation of cryopreserved allograft material in pediatric patients J Thorac Cardiovasc Surg 2000 119 324 330
42. H awkins JA H illman ND L ambert LM et al. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts J Thorac Cardiovasc Surg 2003 126 247 252 (discussion 252-243)
43. S haddy RE H unter DD O sborn KA et al. Prospective analysis of HLA immunogenicity of cryopreserved valved allografts used in pediatric heart surgery Circulation 1996 94 1063 1067
44. D ignan R O 'Brien M H ogan P et al. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens J Heart Valve Dis 2003 12 382 390 (discussion 390-381)
45. W elters MJ O ei FB W itvliet MD et al. A broad and strong humoral immune response to donor HLA after implantation of cryopreserved human heart valve allografts Hum Immunol 2002 63 1019 1025
46. B askett RJ N anton MA W arren AE R oss DB Human leukocyte antigen-DR and ABO mismatch are associated with accelerated homograft valve failure in children: implications for therapeutic interventions J Thorac Cardiovasc Surg 2003 126 232 239
47. S mith JD H ornick PI R asmi N R ose ML Y acoub MH Effect of HLA mismatching and antibody status on ''homovital'' aortic valve homograft performance Ann Thorac Surg 1998 66 S212 S215
48. D e N ofrio D R ho R M orales FJ et al. Detection of anti-HLA antibody by flow cytometry in patients with a left ventricular assist device is associated with early rejection following heart transplantation Transplantation 2000 69 814 818
49. B ishay ES C ook DJ S tarling RC et al. The clinical significance of flow cytometry crossmatching in heart transplantation Eur J Cardiothorac Surg 2000 17 362 369
50. G eorge JF K irklin JK S hroyer TW et al. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients J Heart Lung Transplant 1995 14 856 864
51. R einsmoen NL N elson K Z eevi A Anti-HLA antibody analysis and crossmatching in heart and lung transplantation Transpl Immunol 2004 13 63 71
52. T ambur AR B ray RA T akemoto SK et al. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection Transplantation 2000 70 1055 1059
53. S uciu -F oca N R eed E M arboe C et al. The role of anti-HLA antibodies in heart transplantation Transplantation 1991 51 716 724
54. R eed E C ohen DJ B arr ML et al. Effect of anti-HLA and anti-idiotypic antibodies on the long-term survival of heart and kidney allografts Transplant Proc 1992 24 2494 2495
55. I tescu S T ung TC B urke EM et al. An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients Lancet 1998 352 263 270
56. D onaldson PT A lexander GJ O 'Grady J et al. Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation Lancet 1987 1 945 951
57. L obo PI S pencer C D ouglas MT S tevenson WC P ruett TL The lack of long-term detrimental effects on liver allografts caused by donor-specific anti-HLA antibodies Transplantation 1993 55 1063 1066
58. K aruppan S E riczon BG M oller E Relevance of a positive crossmatch in liver transplantation Transpl Int 1991 4 18 25
59. K atz SM K imball PM O zaki C et al. Positive pretransplant crossmatches predict early graft loss in liver allograft recipients Transplantation 1994 57 616 620
60. S aidman SL D uquesnoy RJ D emetris AJ et al. Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies Transpl Immunol 1994 2 61 67
61. M azariegos GZA R eyes J C hapman H G irnita A Z eevi A Immunologic assays in patients successfully withdrawn from immunosuppression after liver transplantation Am J Transplant 2004 4 301
62. F eucht HE S chneeberger H H illebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss Kidney Int 1993 43 1333 1338
63. M engel M B ogers J B osmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial Am J Transplant 2005 5 1050 1056
64. B aldwin WM III. S amaniego -P icota M K asper EK et al. Complement deposition in early cardiac transplant biopsies is associated with ischemic injury and subsequent rejection episodes Transplantation 1999 68 894 900
65. B ehr TM F eucht HE R ichter K et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies J Heart Lung Transplant 1999 18 904 912
66. I onescu DN G irnita AL Z eevi A et al. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody Transpl Immunol 2005 (in press)
67. M iller GG D estarac L Z eevi A et al. Acute humoral rejection of human lung allografts and elevation of C4d in bronchoalveolar lavage fluid Am J Transplant 2004 4 1323 1330
68. B ohmig GA R egele H E xner M et al. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption J Am Soc Nephrol 2001 12 2482 2489
69. F urth S N eu AM H art J Z achary A C olombani P F ivush BA Plasmapheresis, intravenous cytomegalovirus-specific immunoglobulin and reversal of antibody-mediated rejection in a pediatric renal transplant recipient: a case report Pediatr Transplant 1999 3 146 149
70. J ordan SC V o AA T oyoda M T yan D N ast CC Post-transplant therapy with high-dose intravenous gammaglobulin: Applications to treatment of antibody-mediated rejection Pediatr Transplant 2005 9 155 161
71. B unchman TE P arekh RS K ershaw DB et al. Beneficial effect of Sandoglobulin upon allograft survival in the pediatric renal transplant recipient Clin Transplant 1997 11 604 607
72. M ontgomery RA Z achary AA R acusen LC et al. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients Transplantation 2000 70 887 895
73. S chweizer RT B ow L R oper L H ull D B artus SA Renal transplantation at Hartford hospital: results of combined and flexible immunosuppression Clin Transpl 1988 147 158
74. M ichaels PJ F ishbein MC C olvin RB Humoral rejection of human organ transplants Springer Semin Immunopathol 2003 25 119 140